Buy & Sell Pinterest Inc (PINS) – Pinterest Inc Price Today
Aura AI Summary
Key Stats
- $11.16BMarket Cap
- MediaSector
- -14.59%3M Drawdown
- $11.07BEnterprise Value
- -Dividend Yield
- 2% Buy | 98% SellTrading Activity
- 75 daysTypical Hold Time
Pinterest Inc (PINS) is currently valued at a market capitalization of $11.16B, with an enterprise value of $11.07B. Over the past 52 weeks, Pinterest Inc has traded between a low of $15.42 and a high of $39.17, highlighting its annual price range. Over the past three months, Pinterest Inc has recorded a drawdown of -14.59%, reflecting recent price volatility. On average, investors hold Pinterest Inc for approximately 75 days, indicating typical investor behavior on the platform.
About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Most Recent News
Short seller warns Everspin stock is overvalued amid AI hype, predicts 60% downside.
Kerrisdale Capital has taken a short position on Everspin Technologies, arguing the recent surge in its stock price is driven by misplaced enthusiasm around AI-related memory demand. Everspin's MRAM technology targets niche industrial markets rather ...

Vuzix showcases advanced waveguide smart glasses for defense at SOF Week 2026 in Florida
Vuzix Corporation is exhibiting its advanced AI-powered smart glasses and waveguide solutions at SOF Week 2026 in Tampa, Florida. These products are designed for defense use, offering mission-ready optical performance in challenging environments, inc...

Over 50 companies advance 55+ new pulmonary arterial hypertension drugs in clinical trials.
More than 50 companies are actively developing over 55 new drugs for pulmonary arterial hypertension (PAH), a serious lung-related heart condition. These drugs are in various clinical trial stages, with several in late-stage development, aiming to im...
